Ameriprise’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Sell
85,403
-5,716
-6% -$244K ﹤0.01% 2718
2026
Q1
$3.72M Sell
91,119
-13,843
-13% -$566K ﹤0.01% 2626
2025
Q4
$4.16M Buy
104,962
+402
+0.4% +$15.1K ﹤0.01% 2569
2025
Q3
$4.01M Sell
104,560
-96,171
-48% -$3.57M ﹤0.01% 2594
2025
Q2
$7.46M Buy
200,731
+56,618
+39% +$2.01M ﹤0.01% 2037
2025
Q1
$5.01M Buy
144,113
+10,859
+8% +$363K ﹤0.01% 2314
2024
Q4
$4.31M Buy
133,254
+36,255
+37% +$1.25M ﹤0.01% 2459
2024
Q3
$3.52M Buy
96,999
+419
+0.4% +$14.3K ﹤0.01% 2598
2024
Q2
$2.96M Buy
96,580
+18
+0% +$548 ﹤0.01% 2671
2024
Q1
$3.01M Buy
96,562
+39,163
+68% +$1.11M ﹤0.01% 2662
2023
Q4
$1.66M Buy
57,399
+17,699
+45% +$494K ﹤0.01% 2964
2023
Q3
$1.08M Buy
39,700
+17,000
+75% +$472K ﹤0.01% 3105
2023
Q2
$570K Sell
22,700
-11,100
-33% -$271K ﹤0.01% 3389
2023
Q1
$773K Buy
33,800
+15,700
+87% +$374K ﹤0.01% 3264
2022
Q4
$436K Buy
18,100
+6,300
+53% +$154K ﹤0.01% 3455
2022
Q3
$261K Buy
+11,800
New +$283K ﹤0.01% 3629

Other funds holding ACT

Ameriprise's ACT Position: Q2 2026 in Review

Ameriprise reduced its Enact Holdings (ACT) stake by 6.3% in Q2 2026, selling an estimated $244K and leaving 85,403 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

Ameriprise first reported a position in ACT in Q3 2022 and has held it in 16 quarters since. The position peaked at $7.46M in Q2 2025. 250 funds tracked by Wall St. Rank hold ACT as of Q2 2026.

  • Ameriprise held 85,403 shares of Enact Holdings worth $3.9M as of Q2 2026.
  • Ameriprise sold 5,716 Enact Holdings shares in Q2 2026, an estimated $244K.
  • Enact Holdings made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2718 holding.
  • Ameriprise first reported a position in Enact Holdings in Q3 2022 and has held it in 16 quarters since.
  • Ameriprise's Enact Holdings position peaked at $7.46M in Q2 2025.
  • 250 funds tracked by Wall St. Rank held Enact Holdings as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.